Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar jmt587 (99.85) Submitted: 9/22/2011 2:11:23 PM : Outperform Start Price: $30.24 MRK Score: +6.42

Long Term Outperform.

Report this Post Reply

Featured Broker Partners


Advertisement